In BRCA (breast carcinoma) and LUAD (lung adenocarcinoma), higher CX3CR1 expression was associated with a higher M2 macrophage fraction but a lower M1 macrophage fraction (Figure 3F). Here, CX3CR1 is linked to breast carcinoma.